The American Society of Addiction Medicine has issued a consensus document to guide the appropriate use of drug testing in patients with or at risk for addiction.
The FDA is requiring boxed warnings for opioid analgesics and prescription opioid cough products related to combined use of certain opioids with benzodiazepines.
A recent study tested the efficacy of a psychosocial pain management intervention in adults with chronic pain enrolled in addiction treatment programs.
A recent study evaluated gender differences in substance use, health, and social functioning in people receiving methadone treatment for opioid use disorder.
